Metraipolis › archive › dc_57775177db39
Controlled-Release Nanoparticles for the Treatment of Childhood Refractory Epilepsy in Latin America — Europe PMC PMID:42927454
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42927454
- DOI
- 10.1155/bmri/3576367
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T04:46:24.171Z
- SHA-256 of the archived text
3886cf8bd2b3cccd729a2bbc19f76219d1d367efe48c4581f2b9b1a208da8baa- Stable URL of this page
https://metraipolis.com/documento/dc_57775177db39
How to cite
Controlled-Release Nanoparticles for the Treatment of Childhood Refractory Epilepsy in Latin America — Europe PMC PMID:42927454 — Europe PMC (en), https://europepmc.org/article/MED/42927454 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57775177db39 (Metraipolis archive dc_57775177db39, sha256 3886cf8bd2b3cccd729a2bbc19f76219d1d367efe48c4581f2b9b1a208da8baa)
BibTeX
@misc{dc57775177db39,
title = {Controlled-Release Nanoparticles for the Treatment of Childhood Refractory Epilepsy in Latin America — Europe PMC PMID:42927454},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42927454},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57775177db39; sha256 3886cf8bd2b3cccd729a2bbc19f76219d1d367efe48c4581f2b9b1a208da8baa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42927454. Agents can read the archived copy with the MCP tool read_document.